首页 > 最新文献

Diseases of the Colon & Rectum最新文献

英文 中文
Selected Abstracts.
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-03-01 Epub Date: 2024-12-11 DOI: 10.1097/DCR.0000000000003619
V Prasad Poola, Samuel Eisenstein, Shankar Raman, Mayin Lin
{"title":"Selected Abstracts.","authors":"V Prasad Poola, Samuel Eisenstein, Shankar Raman, Mayin Lin","doi":"10.1097/DCR.0000000000003619","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003619","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":"68 3","pages":"380-384"},"PeriodicalIF":3.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143467290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Features of Lateral Pelvic Lymph Nodes Associated With Pathological Involvement After Total Neoadjuvant Therapy in Patients Undergoing Lateral Pelvic Lymph Node Dissection.
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-03-01 Epub Date: 2024-11-18 DOI: 10.1097/DCR.0000000000003590
Tatsuki Noguchi, Takashi Akiyoshi, Takashi Sakamoto, Shimpei Matsui, Toshiki Mukai, Tomohiro Yamaguchi, Masamichi Koyama, Senzo Taguchi, Eiji Shinozaki, Hiroshi Kawachi, Yosuke Fukunaga
<p><strong>Background: </strong>There is a lack of consensus regarding treating involved lateral pelvic lymph nodes in rectal cancer.</p><p><strong>Objective: </strong>This study aimed to evaluate the clinical and MRI-based factors associated with pathological lateral pelvic lymph node metastasis in patients undergoing total neoadjuvant therapy and lateral pelvic lymph node dissection.</p><p><strong>Design: </strong>This is a retrospective study.</p><p><strong>Settings: </strong>This study was conducted at a single comprehensive cancer center.</p><p><strong>Patients: </strong>A total of 107 patients with advanced low rectal cancer with pretreatment enlarged lateral pelvic lymph nodes (≥7 mm in long axis) undergoing total neoadjuvant therapy with long-course chemoradiotherapy, followed by total mesorectal excision and lateral pelvic lymph node dissection, were enrolled.</p><p><strong>Main outcome measures: </strong>Pathological lateral pelvic lymph node metastasis and survival.</p><p><strong>Results: </strong>Among 107 patients, short-axis lateral node diameter at baseline was <7 mm in 48 patients and ≥7 mm in 59 patients. The ≥7 mm group showed significantly higher rates of pathological lateral pelvic lymph node metastasis (44.1% vs 2.1%; p < 0.0001). In this group, pathological lateral pelvic lymph node metastasis was independently associated with pretreatment malignant features and posttreatment short-axis diameter ≥4 mm. Five-year relapse-free survival was significantly lower in patients with posttreatment lateral node diameter ≥4 mm than those with <4 mm (71.1% vs 86.2%, p = 0.0364). Patients with pathological lateral pelvic lymph node metastasis had significantly lower overall survival, relapse-free survival, and local recurrence-free survival rates.</p><p><strong>Limitations: </strong>Selection bias exists in a retrospective analysis.</p><p><strong>Conclusions: </strong>Pathological lateral pelvic lymph node metastasis is rare in patients with pretreatment short-axis diameter <7 mm. In patients with pretreatment short-axis diameter ≥7 mm, pretreatment malignant features and posttreatment short-axis diameter are both associated with pathological lateral pelvic lymph node metastasis. These factors should be considered when deciding whether to proceed with lateral pelvic lymph node dissection after total neoadjuvant therapy. See Video Abstract.</p><p><strong>Caractersticas de los ganglios linfticos plvicos laterales asociados con afectacin patolgica despus de la terapia neoadyuvante total en pacientes sometidos a diseccin lateral de ganglios linfticos plvicos: </strong>ANTECEDENTES:No existe consenso sobre el tratamiento de los ganglios linfáticos pélvicos laterales afectados en el cáncer rectal.OBJETIVO:Este estudio tuvo como objetivo evaluar los factores clínicos y basados en imágenes de resonancia magnética asociados con la metástasis patológica de los ganglios linfáticos pélvicos laterales en pacientes sometidos a terapia neoadyuvante tota
背景:关于直肠癌受累侧盆腔淋巴结的治疗缺乏共识。目的:本研究旨在评估接受新辅助治疗和侧盆腔淋巴结清扫术的患者中,与病理侧盆腔淋巴结转移相关的临床因素和基于MRI的因素。患者:共纳入了107例晚期低位直肠癌患者,这些患者治疗前盆腔外侧淋巴结肿大(长轴≥7 mm),接受了新辅助治疗和长程化放疗,随后接受了全直肠系膜切除术和盆腔外侧淋巴结清扫术。主要结果指标:病理侧盆腔淋巴结转移和生存率。结果:107 例患者中,基线时短轴侧淋巴结直径为 局限性:回顾性分析存在选择偏倚。结论:接受盆腔侧淋巴结清扫术的患者在接受新辅助治疗后,其盆腔侧淋巴结短轴直径与病理受累相关的特点: 背景:目前对直肠癌盆腔侧淋巴结受累的处理尚未达成共识。设计:这是一项回顾性研究。临床背景:本研究在一家综合癌症中心进行。患者:107例晚期低位直肠癌患者,治疗前盆腔外侧淋巴结肿大(长轴≥7毫米),接受新辅助治疗和长期化放疗,随后接受全直肠系膜切除术和盆腔外侧淋巴结清扫术。主要结局测量指标:病理侧盆腔淋巴结转移率和生存率。结果:107例患者中,48例患者的侧淋巴结直径在短轴线上。
{"title":"Features of Lateral Pelvic Lymph Nodes Associated With Pathological Involvement After Total Neoadjuvant Therapy in Patients Undergoing Lateral Pelvic Lymph Node Dissection.","authors":"Tatsuki Noguchi, Takashi Akiyoshi, Takashi Sakamoto, Shimpei Matsui, Toshiki Mukai, Tomohiro Yamaguchi, Masamichi Koyama, Senzo Taguchi, Eiji Shinozaki, Hiroshi Kawachi, Yosuke Fukunaga","doi":"10.1097/DCR.0000000000003590","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003590","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;There is a lack of consensus regarding treating involved lateral pelvic lymph nodes in rectal cancer.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aimed to evaluate the clinical and MRI-based factors associated with pathological lateral pelvic lymph node metastasis in patients undergoing total neoadjuvant therapy and lateral pelvic lymph node dissection.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;This is a retrospective study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Settings: &lt;/strong&gt;This study was conducted at a single comprehensive cancer center.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patients: &lt;/strong&gt;A total of 107 patients with advanced low rectal cancer with pretreatment enlarged lateral pelvic lymph nodes (≥7 mm in long axis) undergoing total neoadjuvant therapy with long-course chemoradiotherapy, followed by total mesorectal excision and lateral pelvic lymph node dissection, were enrolled.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcome measures: &lt;/strong&gt;Pathological lateral pelvic lymph node metastasis and survival.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Among 107 patients, short-axis lateral node diameter at baseline was &lt;7 mm in 48 patients and ≥7 mm in 59 patients. The ≥7 mm group showed significantly higher rates of pathological lateral pelvic lymph node metastasis (44.1% vs 2.1%; p &lt; 0.0001). In this group, pathological lateral pelvic lymph node metastasis was independently associated with pretreatment malignant features and posttreatment short-axis diameter ≥4 mm. Five-year relapse-free survival was significantly lower in patients with posttreatment lateral node diameter ≥4 mm than those with &lt;4 mm (71.1% vs 86.2%, p = 0.0364). Patients with pathological lateral pelvic lymph node metastasis had significantly lower overall survival, relapse-free survival, and local recurrence-free survival rates.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;Selection bias exists in a retrospective analysis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Pathological lateral pelvic lymph node metastasis is rare in patients with pretreatment short-axis diameter &lt;7 mm. In patients with pretreatment short-axis diameter ≥7 mm, pretreatment malignant features and posttreatment short-axis diameter are both associated with pathological lateral pelvic lymph node metastasis. These factors should be considered when deciding whether to proceed with lateral pelvic lymph node dissection after total neoadjuvant therapy. See Video Abstract.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Caractersticas de los ganglios linfticos plvicos laterales asociados con afectacin patolgica despus de la terapia neoadyuvante total en pacientes sometidos a diseccin lateral de ganglios linfticos plvicos: &lt;/strong&gt;ANTECEDENTES:No existe consenso sobre el tratamiento de los ganglios linfáticos pélvicos laterales afectados en el cáncer rectal.OBJETIVO:Este estudio tuvo como objetivo evaluar los factores clínicos y basados en imágenes de resonancia magnética asociados con la metástasis patológica de los ganglios linfáticos pélvicos laterales en pacientes sometidos a terapia neoadyuvante tota","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":"68 3","pages":"316-326"},"PeriodicalIF":3.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143467255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Significance of Desmoplastic Reaction After Neoadjuvant Chemoradiotherapy in Advanced Rectal Cancer. 晚期直肠癌新辅助放化疗后结缔组织增生反应的预后意义。
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-03-01 Epub Date: 2024-12-03 DOI: 10.1097/DCR.0000000000003589
Shuhei Sano, Takashi Akiyoshi, Noriko Yamamoto, Tatsuki Noguchi, Takashi Sakamoto, Shimpei Matsui, Toshiki Mukai, Tomohiro Yamaguchi, Akinobu Taketomi, Yosuke Fukunaga, Naoki Miyazaki, Hiroshi Kawachi
<p><strong>Background: </strong>Desmoplastic reaction is recognized as a prognostic factor in colorectal cancer. However, its significance in locally advanced rectal cancer after neoadjuvant chemoradiotherapy remains underexplored.</p><p><strong>Objective: </strong>To assess the prognostic value of desmoplastic reaction in specimens from patients with advanced rectal cancer after chemoradiotherapy.</p><p><strong>Design: </strong>This was a retrospective study.</p><p><strong>Settings: </strong>This study was conducted at a single comprehensive cancer center.</p><p><strong>Patients: </strong>The study included 255 patients with advanced rectal cancer who underwent fluoropyrimidine-based chemoradiotherapy followed by total mesorectal excision from 2005 to 2014. Desmoplastic reaction was classified into mature, intermediate, and immature categories based on histological analysis.</p><p><strong>Main outcome measures: </strong>The primary outcomes were recurrence-free survival and overall survival.</p><p><strong>Results: </strong>Desmoplastic reaction was classified as mature (69.0%), intermediate (5.5%), or immature (25.5%). The mature group had a higher percentage of good responders (34.1%) compared with the intermediate (0%) and immature (4.6%) groups ( p < 0.0001). The mature group correlated with better outcomes, with a higher 5-year recurrence-free survival (85.4%) and overall survival (93.0%) as compared with intermediate (45.1% and 76.2%, respectively) and immature (65.8% and 88.8%, respectively) groups. In the multivariable analysis, intermediate/immature desmoplastic reaction was significantly associated with poorer recurrence-free survival ( p = 0.03). Among poor responders, intermediate/immature desmoplastic reaction was associated with poorer recurrence-free survival ( p = 0.03). Adjuvant chemotherapy did not significantly improve the 5-year recurrence-free survival rate for the mature group (adjuvant chemotherapy vs no chemotherapy, 86.4% vs 84.8%; p = 0.64), with worse trends observed in the intermediate/immature combined group (55.9% vs 69.4%, respectively, p = 0.27).</p><p><strong>Limitations: </strong>The limitations include the subjective nature of the desmoplastic reaction assessment and the retrospective design of the study.</p><p><strong>Conclusions: </strong>Desmoplastic reaction in surgical specimens after chemoradiotherapy is associated with responses to chemoradiotherapy and serves as a significant prognostic factor in advanced rectal cancer, particularly for those responding poorly to chemoradiotherapy. See Video Abstract .</p><p><strong>Importancia pronstica de la reaccin desmoplsica tras la quimiorradioterapia neoadyuvante en el cncer rectal avanzado: </strong>ANTECEDENTES:La reacción desmoplásica se reconoce como un factor pronóstico en el cáncer colorrectal. Sin embargo, su importancia en el cáncer rectal localmente avanzado después de la quimiorradioterapia neoadyuvante sigue sin explorarse.OBJETIVO:Evaluar el valor pron
背景:结缔组织增生反应被认为是结直肠癌的预后因素。然而,其在局部晚期直肠癌新辅助放化疗中的意义仍未得到充分探讨。目的:探讨晚期直肠癌放化疗标本中结缔组织增生反应的预后价值。设计:这是一项回顾性研究。环境:本研究在单一的综合性癌症中心进行。患者:该研究纳入了255例晚期直肠癌患者,这些患者在2005年至2014年期间接受了基于氟嘧啶的放化疗,随后进行了全肠系膜切除术。根据组织学分析将结缔组织增生反应分为成熟、中间和未成熟三种。主要结局:主要结局为无复发生存期和总生存期。结果:结缔组织增生反应分为成熟(69.0%)、中度(5.5%)和不成熟(25.5%)。成熟组的良好应答率(34.1%)高于中间组(0%)和未成熟组(4.6%)(p < 0.0001)。成熟组预后更好,5年无复发生存率(85.4%)和总生存率(93.0%)高于中间组(分别为45.1%和76.2%)和未成熟组(分别为65.8%和88.8%)。在多变量分析中,中期/未成熟的结缔组织增生反应与较差的无复发生存率显著相关(p = 0.03)。在不良应答者中,中期/未成熟的结缔组织增生反应与较差的无复发生存率相关(p = 0.03)。辅助化疗未显著提高成熟组5年无复发生存率(辅助化疗vs无化疗,86.4% vs 84.8%;P = 0.64),中间/未成熟联合组的趋势更差(分别为55.9%比69.4%,P = 0.27)。局限性:局限性包括结缔组织增生反应评价的主观性和研究的回顾性设计。结论:手术标本放化疗后的结缔组织增生反应与放化疗反应相关,是晚期直肠癌的重要预后因素,特别是对放化疗反应较差的患者。参见视频摘要。
{"title":"Prognostic Significance of Desmoplastic Reaction After Neoadjuvant Chemoradiotherapy in Advanced Rectal Cancer.","authors":"Shuhei Sano, Takashi Akiyoshi, Noriko Yamamoto, Tatsuki Noguchi, Takashi Sakamoto, Shimpei Matsui, Toshiki Mukai, Tomohiro Yamaguchi, Akinobu Taketomi, Yosuke Fukunaga, Naoki Miyazaki, Hiroshi Kawachi","doi":"10.1097/DCR.0000000000003589","DOIUrl":"10.1097/DCR.0000000000003589","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Desmoplastic reaction is recognized as a prognostic factor in colorectal cancer. However, its significance in locally advanced rectal cancer after neoadjuvant chemoradiotherapy remains underexplored.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To assess the prognostic value of desmoplastic reaction in specimens from patients with advanced rectal cancer after chemoradiotherapy.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;This was a retrospective study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Settings: &lt;/strong&gt;This study was conducted at a single comprehensive cancer center.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Patients: &lt;/strong&gt;The study included 255 patients with advanced rectal cancer who underwent fluoropyrimidine-based chemoradiotherapy followed by total mesorectal excision from 2005 to 2014. Desmoplastic reaction was classified into mature, intermediate, and immature categories based on histological analysis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Main outcome measures: &lt;/strong&gt;The primary outcomes were recurrence-free survival and overall survival.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Desmoplastic reaction was classified as mature (69.0%), intermediate (5.5%), or immature (25.5%). The mature group had a higher percentage of good responders (34.1%) compared with the intermediate (0%) and immature (4.6%) groups ( p &lt; 0.0001). The mature group correlated with better outcomes, with a higher 5-year recurrence-free survival (85.4%) and overall survival (93.0%) as compared with intermediate (45.1% and 76.2%, respectively) and immature (65.8% and 88.8%, respectively) groups. In the multivariable analysis, intermediate/immature desmoplastic reaction was significantly associated with poorer recurrence-free survival ( p = 0.03). Among poor responders, intermediate/immature desmoplastic reaction was associated with poorer recurrence-free survival ( p = 0.03). Adjuvant chemotherapy did not significantly improve the 5-year recurrence-free survival rate for the mature group (adjuvant chemotherapy vs no chemotherapy, 86.4% vs 84.8%; p = 0.64), with worse trends observed in the intermediate/immature combined group (55.9% vs 69.4%, respectively, p = 0.27).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Limitations: &lt;/strong&gt;The limitations include the subjective nature of the desmoplastic reaction assessment and the retrospective design of the study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Desmoplastic reaction in surgical specimens after chemoradiotherapy is associated with responses to chemoradiotherapy and serves as a significant prognostic factor in advanced rectal cancer, particularly for those responding poorly to chemoradiotherapy. See Video Abstract .&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Importancia pronstica de la reaccin desmoplsica tras la quimiorradioterapia neoadyuvante en el cncer rectal avanzado: &lt;/strong&gt;ANTECEDENTES:La reacción desmoplásica se reconoce como un factor pronóstico en el cáncer colorrectal. Sin embargo, su importancia en el cáncer rectal localmente avanzado después de la quimiorradioterapia neoadyuvante sigue sin explorarse.OBJETIVO:Evaluar el valor pron","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":"327-337"},"PeriodicalIF":3.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142767369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Organ Preservation for Locally Advanced Rectal Cancer With Complete Clinical Response After Neoadjuvant Chemoradiotherapy: Bayesian Network Meta-analysis. 新辅助放化疗后完全临床反应的局部晚期直肠癌器官保存的有效性:贝叶斯网络荟萃分析。
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-03-01 Epub Date: 2024-12-05 DOI: 10.1097/DCR.0000000000003484
Kaibo Ouyang, Zifeng Yang, Yuesheng Yang, Zejian Lyu, Junjiang Wang, Yong Li

Background: Neoadjuvant chemoradiotherapy followed by radical surgery is the common treatment for patients with locally advanced rectal cancer. Presently, for patients with complete clinical response after neoadjuvant chemoradiotherapy, organ preservation ("watch-and-wait" and local excision strategies) has been increasingly favored. However, the optimal treatment for patients with complete clinical response remains unclear.

Objective: This study aimed to use Bayesian meta-analysis to determine the best treatment for patients with locally advanced rectal cancer with complete clinical response among radical surgery, local excision, and watch-and-wait strategies.

Data sources: PubMed, Web of Science, Cochrane Library, and Embase (Ovid) databases were searched for literature published through December 31, 2023.

Study selection: Studies that compared 2 or more treatments for patients with complete clinical response were included.

Intervention: The analysis was completed via Bayesian meta-analysis using a random-effects model.

Main outcome measures: Surgery-related complications, local recurrence, distant metastasis, and 5-year overall and disease-free survival rates.

Results: Eleven articles met the inclusion criteria. The watch-and-wait group and local excision group exhibited a higher rate of tumor recurrence compared to the radical surgery group (watch-and-wait vs radical surgery: OR, 9.10 [95% CI, 3.30-32.3]; local excision vs radical surgery: OR, 2.93 [95% CI, 1.05-9.95]). The distant metastasis, overall survival, and disease-free survival rates of the 3 treatments were not statistically different. The radical surgery group had the most number of stomas and had the greatest risk of morbidity than the watch-and-wait group (watch-and-wait vs radical surgery: OR, 0.00 [95% CI, 0.00-0.12]).

Limitations: The study included only 1 randomized controlled trial compared to 10 observational studies, which could affect overall quality. Funnel plots of disease-free survival rates and stoma suggest significant publication bias among studies that compared radical surgery with the watch-and-wait strategy.

Conclusions: The watch-and-wait strategy could be optimal for patients with locally advanced rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy.

背景:新辅助放化疗加根治性手术是局部晚期直肠癌患者的常用治疗方法。目前,对于新辅助放化疗后临床反应完全的患者,器官保存(“观察等待”和局部切除策略)越来越受到青睐。然而,对于完全临床反应的患者,最佳治疗方法仍不清楚。目的:本研究旨在通过贝叶斯荟萃分析确定根治性手术、局部切除和观察等待策略中临床完全缓解的局部晚期直肠癌患者的最佳治疗方案。数据来源:PubMed, Web Of Science, Cochrane Library和Embase(Ovid)检索截止到2023年12月31日。研究选择:纳入比较两种或两种以上临床完全缓解患者治疗的研究。干预:采用随机效应模型,通过贝叶斯元分析完成分析。主要观察结果:手术相关并发症、局部复发、远处转移、5年总生存率和无病生存率。结果:11篇文章符合纳入标准。观察等待组和局部切除组肿瘤复发率高于根治性手术组(OR [95% CI]:观察等待组VS根治性手术组:9.10[3.30,32.3],局部切除组VS根治性手术组:2.93[1.05,9.95])。3种治疗方法的远处转移率、总生存率和无病生存率无统计学差异。根治性手术组造口数量最多,发病风险高于观察等待组(OR[95%CI]:观察等待VS根治性手术组:0.00[0.00,0.12])。局限性:与10项观察性研究相比,本研究仅纳入1项随机对照试验,这可能会影响整体质量。无病生存率和造口的漏斗图表明,在比较根治性手术与观察等待策略的研究中存在显著的发表偏倚。结论:观察等待是局部晚期直肠癌患者新辅助放化疗后临床完全缓解的最佳策略。
{"title":"Effectiveness of Organ Preservation for Locally Advanced Rectal Cancer With Complete Clinical Response After Neoadjuvant Chemoradiotherapy: Bayesian Network Meta-analysis.","authors":"Kaibo Ouyang, Zifeng Yang, Yuesheng Yang, Zejian Lyu, Junjiang Wang, Yong Li","doi":"10.1097/DCR.0000000000003484","DOIUrl":"10.1097/DCR.0000000000003484","url":null,"abstract":"<p><strong>Background: </strong>Neoadjuvant chemoradiotherapy followed by radical surgery is the common treatment for patients with locally advanced rectal cancer. Presently, for patients with complete clinical response after neoadjuvant chemoradiotherapy, organ preservation (\"watch-and-wait\" and local excision strategies) has been increasingly favored. However, the optimal treatment for patients with complete clinical response remains unclear.</p><p><strong>Objective: </strong>This study aimed to use Bayesian meta-analysis to determine the best treatment for patients with locally advanced rectal cancer with complete clinical response among radical surgery, local excision, and watch-and-wait strategies.</p><p><strong>Data sources: </strong>PubMed, Web of Science, Cochrane Library, and Embase (Ovid) databases were searched for literature published through December 31, 2023.</p><p><strong>Study selection: </strong>Studies that compared 2 or more treatments for patients with complete clinical response were included.</p><p><strong>Intervention: </strong>The analysis was completed via Bayesian meta-analysis using a random-effects model.</p><p><strong>Main outcome measures: </strong>Surgery-related complications, local recurrence, distant metastasis, and 5-year overall and disease-free survival rates.</p><p><strong>Results: </strong>Eleven articles met the inclusion criteria. The watch-and-wait group and local excision group exhibited a higher rate of tumor recurrence compared to the radical surgery group (watch-and-wait vs radical surgery: OR, 9.10 [95% CI, 3.30-32.3]; local excision vs radical surgery: OR, 2.93 [95% CI, 1.05-9.95]). The distant metastasis, overall survival, and disease-free survival rates of the 3 treatments were not statistically different. The radical surgery group had the most number of stomas and had the greatest risk of morbidity than the watch-and-wait group (watch-and-wait vs radical surgery: OR, 0.00 [95% CI, 0.00-0.12]).</p><p><strong>Limitations: </strong>The study included only 1 randomized controlled trial compared to 10 observational studies, which could affect overall quality. Funnel plots of disease-free survival rates and stoma suggest significant publication bias among studies that compared radical surgery with the watch-and-wait strategy.</p><p><strong>Conclusions: </strong>The watch-and-wait strategy could be optimal for patients with locally advanced rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy.</p>","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":"287-298"},"PeriodicalIF":3.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142784474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to "Specialization Reduces Cost Associated With Colon Cancer Care: A Cost Analysis". 对 "专业化降低结肠癌治疗相关成本:成本分析"。
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-03-01 Epub Date: 2024-12-10 DOI: 10.1097/DCR.0000000000003621
Fred C Kobylarz, Alice E Lee, Pamela L Burgess
{"title":"Response to \"Specialization Reduces Cost Associated With Colon Cancer Care: A Cost Analysis\".","authors":"Fred C Kobylarz, Alice E Lee, Pamela L Burgess","doi":"10.1097/DCR.0000000000003621","DOIUrl":"10.1097/DCR.0000000000003621","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":"e107"},"PeriodicalIF":3.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142799772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Multimodal Intervention to Increase Total Mesorectal Excision Grading for Rectal Cancer in Michigan: A Randomized Controlled Trial.
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-28 DOI: 10.1097/DCR.0000000000003678
Joceline V Vu, Arielle Kanters, Mariana Berho, Samantha Rivard, Brandy Sinco, Kushal Singh, Ashley Duby, Mousumi Banerjee, Samantha Hendren

Background: The total mesorectal excision technique is associated with improved outcomes for rectal cancer, and grading the total mesorectal excision specimen is recommended. We implemented a multimodal intervention in Michigan Surgical Quality Collaborative hospitals to increase total mesorectal excision grading.

Objective: To compare total mesorectal excision grading rates over time between hospitals that received the intervention early and late in the study.

Design: Stepped wedge randomized controlled trial with hospitals randomized to receive the education intervention early in the trial or one year later. We used a generalized linear mixed model to compare rates of total mesorectal excision grading over time between groups, adjusting for hospital characteristics.

Setting: Twelve hospitals within the Michigan Surgical Quality Collaborative.

Patients: Adult patients undergoing total mesorectal excision for rectal cancer from 2014 to 2021.

Intervention: A multimodal educational intervention consisting of a webinar about total mesorectal excision grading, a pre- and post-webinar quiz, and site visits.

Main outcome measures: Total mesorectal excision grading rate for each hospital over time.

Results: From 2014 to 2021, 560 patients underwent total mesorectal excision in participating hospitals, 350 at early intervention hospitals and 210 in late intervention hospitals. The early intervention began August 2018, and the late intervention began June 2019. Based on the mixed model, grading in early hospitals increased from 8.1% to 99.7% at the end of the study (p < 0.001). In the late group, grading increased from 47.8% to 94.0% (p < 0.001). The intervention was not associated with a change in total mesorectal excision grading in either group; rather, the increase in grading corresponded with a statewide collaborative presentation on this topic in December 2016.

Limitations: Selection bias, as hospitals recruited to participate were already participating in colorectal cancer quality improvement and may reflect greater commitment to high-quality rectal cancer care.

Conclusions: Our findings show an increase in total mesorectal excision grading in Michigan from 2014-2021 that preceded the dates of our intervention. These results highlight the importance of accounting for secular trends in measuring healthcare quality improvement interventions. See Video Abstract.

{"title":"A Multimodal Intervention to Increase Total Mesorectal Excision Grading for Rectal Cancer in Michigan: A Randomized Controlled Trial.","authors":"Joceline V Vu, Arielle Kanters, Mariana Berho, Samantha Rivard, Brandy Sinco, Kushal Singh, Ashley Duby, Mousumi Banerjee, Samantha Hendren","doi":"10.1097/DCR.0000000000003678","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003678","url":null,"abstract":"<p><strong>Background: </strong>The total mesorectal excision technique is associated with improved outcomes for rectal cancer, and grading the total mesorectal excision specimen is recommended. We implemented a multimodal intervention in Michigan Surgical Quality Collaborative hospitals to increase total mesorectal excision grading.</p><p><strong>Objective: </strong>To compare total mesorectal excision grading rates over time between hospitals that received the intervention early and late in the study.</p><p><strong>Design: </strong>Stepped wedge randomized controlled trial with hospitals randomized to receive the education intervention early in the trial or one year later. We used a generalized linear mixed model to compare rates of total mesorectal excision grading over time between groups, adjusting for hospital characteristics.</p><p><strong>Setting: </strong>Twelve hospitals within the Michigan Surgical Quality Collaborative.</p><p><strong>Patients: </strong>Adult patients undergoing total mesorectal excision for rectal cancer from 2014 to 2021.</p><p><strong>Intervention: </strong>A multimodal educational intervention consisting of a webinar about total mesorectal excision grading, a pre- and post-webinar quiz, and site visits.</p><p><strong>Main outcome measures: </strong>Total mesorectal excision grading rate for each hospital over time.</p><p><strong>Results: </strong>From 2014 to 2021, 560 patients underwent total mesorectal excision in participating hospitals, 350 at early intervention hospitals and 210 in late intervention hospitals. The early intervention began August 2018, and the late intervention began June 2019. Based on the mixed model, grading in early hospitals increased from 8.1% to 99.7% at the end of the study (p < 0.001). In the late group, grading increased from 47.8% to 94.0% (p < 0.001). The intervention was not associated with a change in total mesorectal excision grading in either group; rather, the increase in grading corresponded with a statewide collaborative presentation on this topic in December 2016.</p><p><strong>Limitations: </strong>Selection bias, as hospitals recruited to participate were already participating in colorectal cancer quality improvement and may reflect greater commitment to high-quality rectal cancer care.</p><p><strong>Conclusions: </strong>Our findings show an increase in total mesorectal excision grading in Michigan from 2014-2021 that preceded the dates of our intervention. These results highlight the importance of accounting for secular trends in measuring healthcare quality improvement interventions. See Video Abstract.</p>","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143523005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum.
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-26 DOI: 10.1097/DCR.0000000000003712
{"title":"Corrigendum.","authors":"","doi":"10.1097/DCR.0000000000003712","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003712","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143515054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome Following Surgical Treatment for Chronic Pilonidal Sinus Disease: A Systematic Review of Common Surgical Techniques.
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-21 DOI: 10.1097/DCR.0000000000003688
Ida-Marie Myron Wiinblad, Johan Ulrichsen, Birgitte Brandstrup

Background: The choice of operation for chronic pilonidal sinus disease remains controversial.

Objective: To compare the outcomes of common operations for chronic pilonidal disease.

Data sources: We searched PubMed, Embase, and Cochrane Library.

Study selection: We included randomized trials in English or Danish language, published 2002-2024 comparing operations treating chronic pilonidal disease in adults and teenagers.

Interventions: We compared the outcomes of secondary healing, primary midline closure, Bascom's-, Limberg's- and Karydakis' flap operations.

Main outcome measures: The primary outcome was recurrence; secondary outcomes were infection, healing time, and length-of-stay. We compared recurrence and infection rates in meta-analyses for all techniques. We assessed the risk-of-bias and the quality of all trials.

Results: Fifty trials included a total of 5762 participants. In a meta-analysis, the flap-operations had fewer recurrences than primary midline closure (OR 0.31 (95% CI, 0.19 to 0.51, p < 0.01). The trials comparing Flap-operations with secondary healing were heterogeneous and did not reach significance (OR 0.38 (95% CI, 0.13 to 1.13, p = 0.08). Recurrence was similar between Limberg's- and Karydakis' operations. Infection rates were lower for the flap-operations compared with primary closure (OR 0.33 (95% CI, 0.23 to 0.48, p < 0.01) and with secondary healing (OR 0.48 (95% CI, 0.30 to 0.77, p < 0.01). Two trials tested Bascom's procedure against Limberg's operation without significant differences. All trials found secondary healing to have significantly longer healing times than any other operation.

Limitations: Most studies had a high or medium risk-of-bias, resulting in very-low to low certainty of evidence. The trials generally had small numbers, short follow-ups, and no reported primary outcomes or power calculations.

Conclusions: Primary closure and secondary healing performed poorly compared with the flap techniques. Most trials tested Limberg's operation; only 2 tested Bascom's operation. The literature suggests the surgeon's expertise determines the choice of flap technique.

{"title":"Outcome Following Surgical Treatment for Chronic Pilonidal Sinus Disease: A Systematic Review of Common Surgical Techniques.","authors":"Ida-Marie Myron Wiinblad, Johan Ulrichsen, Birgitte Brandstrup","doi":"10.1097/DCR.0000000000003688","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003688","url":null,"abstract":"<p><strong>Background: </strong>The choice of operation for chronic pilonidal sinus disease remains controversial.</p><p><strong>Objective: </strong>To compare the outcomes of common operations for chronic pilonidal disease.</p><p><strong>Data sources: </strong>We searched PubMed, Embase, and Cochrane Library.</p><p><strong>Study selection: </strong>We included randomized trials in English or Danish language, published 2002-2024 comparing operations treating chronic pilonidal disease in adults and teenagers.</p><p><strong>Interventions: </strong>We compared the outcomes of secondary healing, primary midline closure, Bascom's-, Limberg's- and Karydakis' flap operations.</p><p><strong>Main outcome measures: </strong>The primary outcome was recurrence; secondary outcomes were infection, healing time, and length-of-stay. We compared recurrence and infection rates in meta-analyses for all techniques. We assessed the risk-of-bias and the quality of all trials.</p><p><strong>Results: </strong>Fifty trials included a total of 5762 participants. In a meta-analysis, the flap-operations had fewer recurrences than primary midline closure (OR 0.31 (95% CI, 0.19 to 0.51, p < 0.01). The trials comparing Flap-operations with secondary healing were heterogeneous and did not reach significance (OR 0.38 (95% CI, 0.13 to 1.13, p = 0.08). Recurrence was similar between Limberg's- and Karydakis' operations. Infection rates were lower for the flap-operations compared with primary closure (OR 0.33 (95% CI, 0.23 to 0.48, p < 0.01) and with secondary healing (OR 0.48 (95% CI, 0.30 to 0.77, p < 0.01). Two trials tested Bascom's procedure against Limberg's operation without significant differences. All trials found secondary healing to have significantly longer healing times than any other operation.</p><p><strong>Limitations: </strong>Most studies had a high or medium risk-of-bias, resulting in very-low to low certainty of evidence. The trials generally had small numbers, short follow-ups, and no reported primary outcomes or power calculations.</p><p><strong>Conclusions: </strong>Primary closure and secondary healing performed poorly compared with the flap techniques. Most trials tested Limberg's operation; only 2 tested Bascom's operation. The literature suggests the surgeon's expertise determines the choice of flap technique.</p>","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143472308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research Perspective on: Outcome Following Surgical Treatment for Chronic Pilonidal Sinus Disease: A Systematic Review Of Common Surgical Techniques.
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-21 DOI: 10.1097/DCR.0000000000003711
Arielle E Kanters
{"title":"Research Perspective on: Outcome Following Surgical Treatment for Chronic Pilonidal Sinus Disease: A Systematic Review Of Common Surgical Techniques.","authors":"Arielle E Kanters","doi":"10.1097/DCR.0000000000003711","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003711","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143472310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Excision of an Anal Leiomyoma.
IF 3.2 2区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-02-18 DOI: 10.1097/DCR.0000000000003598
Jonathan P Knowles, Benjamin J Goals
{"title":"Excision of an Anal Leiomyoma.","authors":"Jonathan P Knowles, Benjamin J Goals","doi":"10.1097/DCR.0000000000003598","DOIUrl":"https://doi.org/10.1097/DCR.0000000000003598","url":null,"abstract":"","PeriodicalId":11299,"journal":{"name":"Diseases of the Colon & Rectum","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143440236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Diseases of the Colon & Rectum
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1